Immune system involvement in the regulation of ovarian function and augmentation of cancer

被引:24
|
作者
Bukovsky, Antonin [1 ]
机构
[1] Univ Tennessee, Grad Sch Med, Dept Obstet & Gynecol, Lab Dev Differentiat & Canc, Knoxville, TN 37920 USA
关键词
mesenchymal-epithelial interactions; immune system; oogenesis; follicular renewal; corpus luteum; cancer;
D O I
10.1002/jemt.20307
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Increasing evidence indicates a role for the immune system and mesenchymal-epithelial interactions in the regulation of ovarian function. Cytokines produced by mesenchymal cells can stimulate development and regression of ovarian structures. We report here that mesenchymal cells releasing surface molecules among epithelial cells-namely vascular pericytes and monocyte-derived cells (MDC)-and intraepithelial T lymphocytes are associated with oogenesis and formation of new primary follicles in both fetal and adult human ovaries. These activated mesenchymal cells interact with the ovarian surface epithelium, which appears to be a source of secondary germ cells and granulosa cells. Activated pericytes and MDC are also associated with stimulation of thecal development during selection of growing secondary follicles from the cohort of primary follicles. However, survival of the dominant follicle during mid-follicular phase selection is associated with a lack of activity of mesenchymal cells and retardation of thecal development, since immature granulosa cells lacking aromatase are unable to resist high levels of thecal androgens. Once the selected follicle matures (late follicular phase), it shows enhanced activity of thecal mesenchymal cells and advanced thecal development. Corpus luteum (CL) development is accompanied by a high activity of vascular pericytes and MDC. In mature CL and CL of pregnancy, luteal MDC and pericytes show a stable (inactive) state. Regression of the CL is associated with regression of pericytes, transformation of MDC into dendritic cells, infiltration by T lymphocytes, and binding of immunoglobulin G to the luteal cells. The immunoglobulin M (IgM) binds to young but not mature luteal cells. In the CL of pregnancy, IgM binds to luteal vessels, but not to luteal cells. Regressing CL shows IgM binding to both luteal cells and vessels. In ovarian cancers, highly activated MDC and sometimes activated pericytes (poorly differentiated carcinomas) are present. IgM binding is similar to that seen in the CL of pregnancy. These data indicate that vascular pericytes, MDC, T cells, and immunoglobulins may play an important role in the regulation of ovarian physiology and contribute to the augmentation of ovarian cancer growth.
引用
收藏
页码:482 / 500
页数:19
相关论文
共 50 条
  • [41] Activated immune system in associated with poor prognosis in ovarian cancer
    Marth, C
    Windbichler, G
    Zeimet, AG
    Daxenbichler, G
    Graf, A
    Stummvoll, W
    Fuchs, D
    [J]. 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, : 247 - 251
  • [42] Biomarkers of Central Nervous System Involvement from Epithelial Ovarian Cancer
    Scotto, Giulia
    Borella, Fulvio
    Turinetto, Margherita
    Tuninetti, Valentina
    Valsecchi, Anna A.
    Giannone, Gaia
    Cosma, Stefano
    Benedetto, Chiara
    Valabrega, Giorgio
    [J]. CELLS, 2021, 10 (12)
  • [43] RNAi and RNA-based regulation of immune system function
    Chowdhury, D
    Novina, CD
    [J]. ADVANCES IN IMMUNOLOGY, VOL 88, 2005, 88 : 267 - 292
  • [44] The importance of vascular immune regulation in the prognosis of women with advanced ovarian cancer.
    Chan, JK
    Magistris, A
    Loizzi, V
    Rutgers, J
    Osann, K
    DiSaia, PJ
    Samoszuk, M
    [J]. JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (02) : 401A - 401A
  • [45] Prosurvival function and up-regulation of Twist in human ovarian cancer
    Wang, Qi
    Sun, Mei
    Nicosia, Santo V.
    Cheng, Jin Q.
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [46] Integrated analysis reveals microRNA mediated immune system regulation in advanced epithelial ovarian cancer associated with clinical prognosis
    Korsunskiy, I.
    Lovecchio, J. L.
    Menzin, A. W.
    Whyte, J. S.
    Dos Santos, L.
    Liang, S.
    Bhuiya, T.
    Mason, C.
    Khalili, H.
    Shih, A.
    Gregersen, P.
    Lee, A.
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 145 : 75 - 75
  • [47] Immune editing in ovarian cancer
    Harper, S.
    Al-Atttar, A.
    Rolland, P.
    Durrant, L.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2009, 116 (10) : 1409 - 1409
  • [48] The effect of extensive surgery on the immune system in women with advanced ovarian cancer
    Brochner, A. C.
    Mikkelsen, S.
    Hegelund, I
    Mogensen, O.
    Toft, P.
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2009, 53 : 74 - 74
  • [49] Protein 90K stimulates the immune system in ovarian cancer
    Zeimet, AG
    Marth, C
    Fuchs, D
    Herold, M
    Widschwendter, M
    Daxenbichler, G
    Iacobelli, S
    Dapunt, O
    [J]. GYNAKOLOGISCH-GEBURTSHILFLICHE RUNDSCHAU, 1996, 36 (01): : 44 - 45
  • [50] Immune regulation of ovarian development: programming by neonatal immune challenge
    Sominsky, Luba
    Sobinoff, Alexander P.
    Jobling, Matthew S.
    Pye, Victoria
    McLaughlin, Eileen A.
    Hodgson, Deborah M.
    [J]. FRONTIERS IN NEUROSCIENCE, 2013, 7